Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MA09-hRPE in advanced dry AMD
NCT01674829Phase 2Terminated
- Sponsor
- CHA Biotech
- Start
- Sep 2012
- Primary completion
- Sep 2017
- Modality
- Patient-derived iPSCs, Allogeneic iPSCs
- Countries
- 1
01
Overview
A Phase 2 trial of ASP7317 in age-related macular degeneration (AMD), sponsored by CHA Biotech. Started Sep 2012; status: terminated.
02
Drugs
ASP7317
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT01674829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01674829.